Hesperidin Modulates Troponin-1 Serum Level and Decrease Heart Tissue Injury of Irradiated Rats.
J Biomed Phys Eng
; 11(3): 377-388, 2021 Jun.
Article
em En
| MEDLINE
| ID: mdl-34189126
ABSTRACT
BACKGROUND:
The heart is the major dose-limiting organ for radiotherapy of malignant tumor in the mediastanal region.OBJECTIVE:
This study aims to investigate the radio protective effects of Hesperidin (HES) as a natural flavonoid after localized irradiation of the rat's mediastinum region. MATERIAL ANDMETHODS:
In this experimental study, we divided sixty male rats into 4 groups (n=15). First group Sham which received PBS; second group Hesperidin only (100 mg/kg/day orally) for one week; third group Radiation that received single dose of 20 Gy gamma radiation using Co-60 unit and the forth group Radiation+HES that underwent the same dose of radiation and received HES for 7 days prior irradiation. Each group was divided in two branches. Early sampling from subgroup one was done 4-6 hours after irradiation to determine troponin-1 level changes. Rats of second subgroups were killed 56 days after irradiation for histopathological evidence.RESULTS:
In radiation group, troponin -1 serum level had a significant increase in comparison with sham group (P<0.05). Histopathological evaluation of second subgroup showed there was a significant difference between sham and radiation group in some parameters. Inflammation (p=0.008), pericardial effusion (P=0.001), and vascular plaque (P=0.001) had an increase in the irradiation group. Oral administration of hesperidin significantly decreased all the above factors when was compared with irradiation group (P>0.016).CONCLUSION:
Oral administration of Hesperidine for seven days prior radiotherapy may decrease troponin-1 and cardiac injury due to radiation.
Texto completo:
1
Base de dados:
MEDLINE
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article